BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Dr Nitin Mishra speaks to ecancer at the SLAGO 2019 meeting in Chile about the new surgeries in rectal cancer.
He explains primarily the main differences between robotic surgeries in the USA and Latin America, and how it to introduce some surgery techniques into Latin America.
Dr Mishra thinks the best way to start reducing these cancer deaths would be through screening.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
New classification for identifying HR myeloma based on cytogenetic abnormalities
Tele-mentoring: Impact of project ECHO
Powering equity in cancer care through digital health
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Colorectal cancer risk factors in Nigeria
SABCS 2023: Latest breast cancer diagnostics guidelines
Lung Cancer
Choosing Wisely in pathology